Trump Gains More Credit Than Biden for Lowering Drug Prices Amid Industry Pushback

Recent reports indicate that Donald Trump is being more widely credited than President Biden for efforts to lower drug prices. This shift reflects increased industry resistance alongside Trump's initiatives in this area. Watching the upcoming policy developments will be crucial to see if this credit translates into tangible legislative changes or impacts public health outcomes.